Virax Biolabs Group Limited Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| SQUAREPOINT OPS LLC | 11/14/2024 | 40,620 | $78,803 | 100.00% | 2.02% |
| UBS GROUP AG | 11/14/2024 | 20,530 | $39,828 | 266.54% | 1.02% |
| JANE STREET GROUP, LLC | 11/15/2024 | 11,635 | $22,572 | 100.00% | 0.58% |
| HEADLANDS TECHNOLOGIES LLC | 11/12/2024 | 185 | $359 | 311.11% | 0.01% |
| HRT FINANCIAL LP | 11/12/2024 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 0 | $0 | -100.00% | 0.00% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
Virax Biolabs Group Limitedinstitutional Ownership - FAQ's
During the previous two years, 7 institutional investors and hedge funds held shares of Virax Biolabs Group Limited. The most heavily invested institutionals were:
Squarepoint Ops LLC: 40,620
UBS Group AG: 20,530
JANE STREET GROUP, LLC: 11,635
Headlands Technologies LLC: 185
Qube Research & Technologies Ltd: 0
Virtu Financial LLC: 0
10.88% of Virax Biolabs Group Limited stock is owned by institutional investors.
Institutional investors have bought a total of 72,970 shares in the last 24 months. This purchase volume represents approximately $120,401 in transactions.